Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics Inc. (DMAC) Cash from Operations (2018 - 2019)

DiaMedica Therapeutics (DMAC) has 2 years of Cash from Operations data on record, last reported at 1865000.0 in Q4 2019.

  • For Q4 2019, Cash from Operations rose 1.84% year-over-year to 1865000.0; the TTM value through Dec 2019 reached 9102000.0, down 59.8%, while the annual FY2024 figure was 22076000.0, 17.88% down from the prior year.
  • Cash from Operations reached 1865000.0 in Q4 2019 per DMAC's latest filing, down from 1232000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 935000.0 in Q1 2018 and bottomed at 3134000.0 in Q1 2019.